ATE260109T1 - Darmentzündungen vorbeugendes und therapeutisches arzneimittel - Google Patents

Darmentzündungen vorbeugendes und therapeutisches arzneimittel

Info

Publication number
ATE260109T1
ATE260109T1 AT97947879T AT97947879T ATE260109T1 AT E260109 T1 ATE260109 T1 AT E260109T1 AT 97947879 T AT97947879 T AT 97947879T AT 97947879 T AT97947879 T AT 97947879T AT E260109 T1 ATE260109 T1 AT E260109T1
Authority
AT
Austria
Prior art keywords
hydrogen atom
active ingredient
alkyl group
lower alkyl
intestinal diseases
Prior art date
Application number
AT97947879T
Other languages
English (en)
Inventor
Toshikazu Yoshikawa
Norimasa Yoshida
Hironobu Murase
Original Assignee
Cci Corp
Toshikazu Yoshikawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cci Corp, Toshikazu Yoshikawa filed Critical Cci Corp
Application granted granted Critical
Publication of ATE260109T1 publication Critical patent/ATE260109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97947879T 1996-12-10 1997-12-10 Darmentzündungen vorbeugendes und therapeutisches arzneimittel ATE260109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8329901A JPH10168095A (ja) 1996-12-10 1996-12-10 炎症性腸疾患予防および治療剤
PCT/JP1997/004544 WO1998025629A1 (en) 1996-12-10 1997-12-10 Prophylactic and therapeutic agent for inflammatory intestinal diseases

Publications (1)

Publication Number Publication Date
ATE260109T1 true ATE260109T1 (de) 2004-03-15

Family

ID=18226533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97947879T ATE260109T1 (de) 1996-12-10 1997-12-10 Darmentzündungen vorbeugendes und therapeutisches arzneimittel

Country Status (9)

Country Link
US (1) US6174864B1 (de)
EP (1) EP0965344B1 (de)
JP (1) JPH10168095A (de)
KR (1) KR100467470B1 (de)
CN (1) CN1125640C (de)
AT (1) ATE260109T1 (de)
CA (1) CA2274575C (de)
DE (1) DE69727836T2 (de)
WO (1) WO1998025629A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000045824A1 (fr) * 1999-02-02 2000-08-10 Cci Corporation Agents preventifs et curatifs contre l'arteriosclerose
EP1174140B1 (de) * 1999-03-31 2009-11-11 Cci Corporation Chromanol glycoside zur behandlung von durch ultraviolettes licht verursachten dermopathien
ATE493993T1 (de) * 2002-03-26 2011-01-15 Tsutomu Kagiya Chromanol glucoside zur verbesserung der chemischen krebsbehandlung
AU2003291012A1 (en) * 2002-11-15 2004-06-15 Galileo Pharmaceuticals, Inc. Chroman derivatives for the reduction of inflammation symptoms
US7709525B2 (en) * 2003-02-27 2010-05-04 Wisconsin Alumni Research Foundation Chroman-derived anti-androgens for treatment of androgen-mediated disorders
JP2004269460A (ja) * 2003-03-11 2004-09-30 Cci Corp 消化性潰瘍の予防および治療剤
DE102004025791A1 (de) * 2004-05-19 2005-12-15 Schering Ag Chromanol-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
JP5336175B2 (ja) * 2005-03-15 2013-11-06 ガニアル・イミュノセラピューティクス・インコーポレーテッド 免疫調整剤活性を有する化合物
BRPI0620734A2 (pt) † 2005-12-29 2012-09-18 Hill's Pet Nutrition, Inc método para melhorar o equilìbrio de bactérias benéficas e nocivas no trato gastrintestinal de um animal, uso de pelo menos um antioxidante, composição de ração, kit, e meio para comunicação de informação e/ou instruções
ITMI20080846A1 (it) * 2008-05-09 2009-11-10 Andrea Balsari Composti a struttura glicosidica attivi nella terapia di stati infiammatori locali e sistemici
CN102596982B (zh) * 2009-03-31 2015-03-18 Cci有限公司 腹膜肥厚抑制剂
CN112351783A (zh) * 2018-06-07 2021-02-09 国立大学法人大阪大学 氧化应激诱发的疾病的预防或治疗药物
KR101993780B1 (ko) 2018-09-03 2019-07-01 서형바이클랙주식회사 가정용 자전거 거치대
KR102081084B1 (ko) 2019-06-25 2020-02-25 박흥일 탈부착용 자전거 리프트 랙
KR102231742B1 (ko) 2020-06-01 2021-03-24 박흥일 도난방지 기능을 구비한 자전거 주차정산 시스템

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2543627B2 (ja) 1990-02-09 1996-10-16 帝人株式会社 活性型ビタミンｄ含有治療剤
EP0550292A1 (de) * 1992-01-02 1993-07-07 Merrell Dow Pharmaceuticals Inc. Tocopherol-Analog zum Gewebeschutz
JPH05246847A (ja) 1992-03-04 1993-09-24 Eisai Co Ltd 潰瘍性大腸炎治療・予防剤
US5639770A (en) 1992-05-29 1997-06-17 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives
JP3385387B2 (ja) 1992-05-29 2003-03-10 大塚製薬株式会社 チアゾール誘導体
US5294630A (en) 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
JP3550412B2 (ja) * 1993-02-10 2004-08-04 シーシーアイ株式会社 新規なクロマノール配糖体およびその製造方法
WO1994026269A1 (en) 1993-05-10 1994-11-24 Sepracor, Inc. Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
EP0640609A1 (de) 1993-08-24 1995-03-01 Ono Pharmaceutical Co., Ltd. Kondensierte Phenolderivate mit Hemmwirkung auf TXA2 Synthetase und 5-Lipoxygenase, und zum Abfangen von Säuerstoffverbindungen
JPH07112980A (ja) * 1993-08-24 1995-05-02 Ono Pharmaceut Co Ltd 縮合フェノール誘導体およびその誘導体を有効成分として含有する薬剤
JPH07316150A (ja) 1994-05-24 1995-12-05 Ono Pharmaceut Co Ltd 縮合フェノール誘導体
GB9504460D0 (en) 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
JP3703875B2 (ja) * 1995-04-03 2005-10-05 シーシーアイ株式会社 クロマノール配糖体およびその製造方法

Also Published As

Publication number Publication date
CA2274575C (en) 2009-11-24
DE69727836D1 (de) 2004-04-01
JPH10168095A (ja) 1998-06-23
EP0965344A4 (de) 2003-05-02
WO1998025629A1 (en) 1998-06-18
CA2274575A1 (en) 1998-06-18
US6174864B1 (en) 2001-01-16
EP0965344B1 (de) 2004-02-25
KR100467470B1 (ko) 2005-01-24
CN1125640C (zh) 2003-10-29
EP0965344A1 (de) 1999-12-22
DE69727836T2 (de) 2004-12-30
KR20000057457A (ko) 2000-09-15
CN1245430A (zh) 2000-02-23

Similar Documents

Publication Publication Date Title
ATE260109T1 (de) Darmentzündungen vorbeugendes und therapeutisches arzneimittel
ES2199260T3 (es) Agentes eficaces contra los estados cutaneos deficitarios, hiperactivos asi como dermatitides manifiestas.
EP0727217A2 (de) Pharmazeutische und kosmetische Zusammensetzungen enthaltend God-Typ-Ellagitannin als Wirkstoff
BR9914878A (pt) Composições farmacêuticas contendo inibidores da poli (adp-ribose) glicohidrolase e métodos de sua utilização
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
CA2263203A1 (en) 3,6-ketal and enol ether macrolide antibiotics
BRPI0114042B8 (pt) uso de composto bicíclico na fabricação de uma composição para alívio ou prevenção de constipação em um paciente humano constipado e limpeza de intestinos
JPS61280424A (ja) 創傷治癒剤
FI925926A0 (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
JPS6431707A (en) Dermal agent for external use
ATE260639T1 (de) Sialylzucker und ihre derivaten enthaltende topische zubereitungen
KR20080015762A (ko) 멜라닌 저색소증 질환 개선제 조성물
MXPA01007042A (es) Composiciones que comprenden al menos un filtro de radiaciones uv y una sal de flavilio no sustituida en la posicion 3 para la coloracion de la piel y utilizaciones.
DE69312567D1 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
DE69311618D1 (de) Halbsynthetische Glykosaminoglykane, die in 3-Position mit nukleophilen Radikalen substituierte alpha-L-Galakturonsäure enthalten
CN108309866B (zh) 一种含有甘草提取物的成人沐浴露
ES2059120T3 (es) Agente de limpieza liquido acuoso.
JP3232137B2 (ja) 活性酸素消去剤
JPS6413018A (en) Skin-beautifying cosmetic
AU762097B2 (en) Benzo(b)pyran derivatives useful as external agents for the skin
JPH05279225A (ja) タンニング促進化粧料組成物
CO4980848A1 (es) Composicion farmaceutica o cosmetica que contiene una combi- nacion de al menos un retoide con al menos un oligosacarido que sirve para el tratamiento cosmetico del envejecimiento de la piel y/o el darmato esqueleto
WO2025137844A1 (en) Cosmetic compositions comprising robinin
ATE309823T1 (de) Prophylaxe und heilmittel für mit ischemie- reperfusion zusammenhängende erkrankungen
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties